Unique ID issued by UMIN | UMIN000036485 |
---|---|
Receipt number | R000041570 |
Scientific Title | Effect of the compound supplements on QOL in adult men after ingestion of the supplements for 8 weeks |
Date of disclosure of the study information | 2019/04/15 |
Last modified on | 2020/04/13 10:25:34 |
Effect of the compound supplements on QOL in adult men
Effect of the compound supplements on QOL in adult men
Effect of the compound supplements on QOL in adult men after ingestion of the supplements for 8 weeks
Effect of the compound supplements on QOL in adult men after ingestion of the supplements for 8 weeks
Japan |
Male menopausal symptoms
Adult |
Others
NO
To investigate the effect of the compound supplements on QOL in adult men after ingestion of the supplements for 8 weeks.
Efficacy
Change in fatigue VAS after ingestion of the supplements for 8 weeks.
Changes in AMS score anti aging,QOL total blood testosterone and free blood testosteronea after ingestion of the supplements for 8 weeks.
Observational
20 | years-old | <= |
75 | years-old | > |
Male
1)Japanese male aged 20 to 75 at the time of informed consent.
2)Subjects who made a visit to outpatient clinic for male menopause and are diagnosed not to need medication for male menopause symptoms.
3) Subjects who need watch and wait and decide to use health food and the like by their own will for the purpose of nutrition support that is insufficient in the diet..
4) Subjects who will intake the compound supplements.
1)Subjects who are suspected to have serious disease such as digestive, liver, kidney, circulatory, blood, and endocrine disorder or who have the history of these disorders.
2) Subjects who are judged to require testosterone replacement therapy at outpatient clinic
3)Subjects who are judged to require administration of PDE-5 inhibitor at outpatient clinic
4)Subjects who are judged to require the administration of antidepressants or anti-anxiety drug at outpatient clinics
5)Subjects who are currently taking a supplement which contains a same functional substance as the compound supplements
6)Subjects who may cause allergic reactions to foods
7)Subjects who are heavy smoker or heavy user of alcohol
8)Subjects who are judged as unsuitable for the study by the investigator with other reasons.
40
1st name | Kei |
Middle name | |
Last name | Yui |
FANCL Corporation
Research Institute
045-820-3569
Kamishinano 12-13, Totsuka-ku, Yokohama, Kanagawa
045-820-3659
tsubokawa_masaya@fancl.co.jp
1st name | Isao |
Middle name | |
Last name | Takehara |
Clinical Support Corpration
Food Service Division
060-0061
12-13 Kamishinano, Totsuka-ku, Yokohama, Kanagawa, Japan
045-820-3569
takehara@csc-smo.co.jp
FANCL Corporation
FANCL Corporation
Profit organization
Medical corporation Hokubukai beauty hill hospital ethics review committee
No. 61, Maeda, Kiyota-ku, Sapporo, Hokkaido
011-882-0111
wakimoto@ughp-cpc.jp
NO
2019 | Year | 04 | Month | 15 | Day |
Unpublished
45
Completed
2019 | Year | 02 | Month | 26 | Day |
2019 | Year | 03 | Month | 20 | Day |
2019 | Year | 04 | Month | 15 | Day |
2020 | Year | 03 | Month | 31 | Day |
None
2019 | Year | 04 | Month | 12 | Day |
2020 | Year | 04 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000041570
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |